This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BOSTON, July 10, 2013 (GLOBE NEWSWIRE) -- PAREXEL International Corporation (Nasdaq:PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2013 on Wednesday, August 7, 2013 after the close of the stock market. The announcement will be available on PAREXEL's website at
www.PAREXEL.com and on the PR Newswire website at
PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, August 8, 2013 to discuss the results. To access the webcast, visit PAREXEL's website at
www.PAREXEL.com , and click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL's Fourth Quarter and Fiscal Year 2013 conference call.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 78 locations in 52 countries around the world, and has approximately 14,400 employees. For more information about PAREXEL International visit
PAREXEL, Perceptive Informatics, LIQUENT, and HERON are registered trademarks of PAREXEL International Corporation or its affiliates.
CONTACT: James Winschel, Senior Vice President
and Chief Financial Officer
Jill Baker, Corporate Vice President, Investor Relations